News
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President Donald Trump's executive order to ...
Going forward, Ypsomed will focus on its self-injectors for subcutaneous drug ... Ypsomed inks deal to manufacture GLP-1 autoinjectors for Novo Nordisk Ypsomed, meanwhile, said it will establish ...
Novo Nordisk (NYSE: NVO), the Danish drugmaker that's been riding high ever since it began putting out Ozempic and Wegovy GLP-1 injectables for treatment of diabetes and weight loss, got another ...
Patients self-administer, through injection, the Novo Nordisk and Lilly drugs, and they do this on a weekly basis. The pharma giants aren't stopping there, though. The next big achievement in this ...
Shares of Novo Nordisk ... based injection drugs Zepbound and Mounjaro instead. Over the past six months, its once-ascendant stock value is down a grim 50 percent. While Novo Nordisk is getting ...
Weight loss leader Novo Nordisk has had a poor performance at the stock markets year-to-date [YTD] even as the healthcare sector is among the least impacted ones. The key reason for this is ...
It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...
Elizabeth Pennell alleges that Novo Nordisk A/S, the drug’s manufacturer, should have been aware of the potential risk of blindness associated with the medication. Pennell, who was using Ozempic to ...
Conduct CT in India: CDSCO Panel tells Novo Nordisk India For new formulation of Semaglutide tablets
This came as Novo Nordisk India sought approval for Semaglutide tablets of 1.5 mg, 4 mg, and 9 mg of a new formulation based on the BE studies conducted in the USA and Canada. In light of earlier SEC ...
Emkay said the two-wheeler segment is expected to post approximately 6 percent revenue growth in Q4FY25, supported by 20 percent and 11 percent growth at Eicher Motors and TVS Motor respectively.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results